Hand sanitizer turned into a pocket-sized security blanket over the past few years, but it was never designed to solve every mess you get on your hands. When you are dealing with grease, grime, ...

After reportedly flirting with going public for years, the artificial intelligence-powered drug developer Insilico Medicine has laid out plans to raise about $292 million through a listing on the ...

FRANKFORT, Ky. (WOWK) — Kentucky Governor Andy Beshear announced on Monday that bromazolam, also known as “Designer Xanax,” received an emergency designation as a Schedule I controlled substance. As a ...

HGTV's David Bromstad has revealed he checked himself into rehab as he grappled with substance abuse during his extensive house renovation. The television personality and designer, 52, sought ...

The star-studded action-thriller series helmed by Ryan Murphy finally has its first trailer – and it’s every bit as beautiful, hot, and sexy as you would expect from the title. But beneath the glitz, ...

President Donald Trump on Friday, Dec. 19, announced nine pharmaceutical companies have agreed to sell medications at lower prices, part of his administration's effort to lower drug prices to levels ...

There's just not enough time to cover them all, and 2025 was packed with gems you probably haven't heard of. For those ...

The U.S. military says it struck two more alleged drug-carrying boats on Thursday, bringing the total death toll from the Trump administration's monthslong campaign to upwards of 100. The latest two ...

Ryan Murphy’s upcoming series The Beauty has unveiled its first official trailer, offering a chilling look at a world where physical perfection comes at a devastating cost. The FX Networks production, ...

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 ...

In the last Fierce Pharma Asia weekly news roundup of 2025, Daiichi Sankyo scored a key FDA approval for AstraZeneca-partnered Enhertu in first-line HER2-positive breast cancer but paused a phase 3 ...